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Abstract Many succinate:quinone oxidoreductases in bacteria 
and mitochondria, i.e. succinate:quinone r ductases and fuma- 
rate reductases, contain in the membrane anchor a cytochrome b
whose structure and function is poorly understood. Based on 
biochemical data and polypeptide sequence information, we show 
that the anchors in different organisms are related despite an 
apparent diversity in polypeptide and heine composition. A 
general structural model for the membrane-integral domain of 
the anchors is proposed. It is an antiparallel four-helix bundle 
with a novel arrangement of hexa-coordinated protoheme IX. 
The structure can be applied to a larger group of membrane- 
integral cytochromes of b-type and has evolutionary and 
functional implications. 
Key words: Succinate dehydrogenase; Fumarate reductase; 
Cytochrome b; Heme protein; Quinone reductase 
1. Introduction 
Succinate:quinone r ductase (SQR; EC 1.3.5.1) in aerobic 
cells is a functional part of both the Krebs' cycle and the 
respiratory chain. This membrane-bound enzyme is also called 
complex II or succinate dehydrogenase. It catalyses the oxida- 
tion of succinate to yield fumarate and reduces quinone. SQR 
in many organisms contains cytochrome of b-type [1,2]. The 
function and structure of this cytochrome is poorly under- 
stood as compared to that of the cytochrome bc/bf (complex 
III, quinol:cytochrome c reductase) and cytochrome c oxidase 
(complex IV) [3-5]. 
Anaerobic ells respiring with fumarate as terminal electron 
acceptor contain quinol:fumarate r ductase (QFR) [6,7]. This 
enzyme is very similar to SQR in composition, and probably 
also in structure; in vitro QFRs and SQRs can generally both 
catalyse succinate oxidation and fumarate reduction, but at 
different rates. In this paper we collectively refer to SQRs and 
QFRs as succinate:quinone oxidoreductases (for review see 
[1,2,8,9]). 
Succinate:quinone oxidoreductases consist of a peripheral 
domain, exposed to the cytoplasm in bacteria nd to the ma- 
trix in mitochondria, and a membrane-integral domain that 
spans the membrane (Fig. 1). The peripheral domain, which 
contains the dicarboxylate binding site and several redox 
(electron-transfer) components, is very conserved with respect 
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to composition and primary sequence of polypeptides when 
the enzymes from different organisms are compared. It is 
composed of a flavoprotein (Fp; 64-79 kDa) subunit, with 
one covalently bound FAD, and an iron-sulfur protein (Ip; 
27-31 kDa) subunit containing one each of a [2Fe-2S], a [3Fe- 
4S], and a [4Fe-4S] cluster. The membrane-integral domain 
functions to anchor the Fp and Ip subunits to the membrane 
and is required for quinone reduction and oxidation. This 
anchor domain consists of one larger (SdhC/FrdC; 23-30 
kDa) or two smaller (Cn_3/SdhC/FrdC and Cn_4/SdhD/ 
FrdD; 13-18 and 11-16 kDa) hydrophobic polypeptides con- 
taining one or two protoheme IX groups with hexa-coordi- 
nated iron, or no heme at all. When two hemes are present 
they have different spectral and thermodynamic properties. In 
addition to this variability in macromolecular composition the 
amino acid sequences of the membrane-anchor polypeptides 
show poor apparent similarity. For example, sequence com- 
parisons using conventional computer programs like TFAS- 
TA [10] often do not result in the identification of the anchor 
polypeptides (cf. [11]). 
In this minireview e present an update on the membrane- 
anchor proteins of succinate:quinone oxidoreductases from 
different organisms. It is shown that they are related and we 
propose and discuss a general structural model for the mem- 
brane-integral domain of succinate:quinone reductases. 
2. Classification of membrane anchors 
The membrane-anchor domain of succinate:quinone oxido- 
reductases can be classified into 4 types, here denoted A-D,  
based on differences in polypeptide and heme composition (Ta- 
ble 1). Type A, so far only represented by the Thermoplasma 
acidophilum SQR, has two polypeptides and two heine groups. 
Type B has a single polypeptide and two hemes. Examples of 
this type are Bacillus subtilis SQR and Wolinella succinognes 
QFR. Type C, with two polypeptides and one heme, seems to 
be the most common type and is found in mammalian mito- 
chondrial and Escherichia coli SQR. Type D anchors contain 
two polypeptides without heme. This latter type is present in 
E. coli QFR, S. acidocaldarius (Sulfolobus p. strain 7) SQR 
and seemingly in Saccharomyces cerevisiae SQR. 
3. Transmembrane topology of anchor polypeptides 
It is known from surface-labelling experiments with mam- 
malian and B. subtilis SQR in situ that the anchor domain 
spans the mitochondrial inner membrane and the cytoplasmic 
membrane, respectively [1,2]. The two polypeptides in type A, 
C and D anchors both show a common pattern of 3 stretches 
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with hydrophobic amino acids predicted to constitute trans- 
membrane a-helical segments in the membrane-spanning 
folded proteins. The single polypeptide anchors, i.e. those of 
type B, contain 5 such predicted transmembrane s gments. 
Experimental data with the B. subtilis anchor polypeptide, 
SdhC, confirm the presence of 5 transmembrane segments in 
this protein and show that the N-terminal end is exposed to 
the cytoplasm [12]. The topology of this protein and those 
predicted for the T. acidophilum and E. coli SdhC and 
SdhD polypeptides are illustrated in the top part of Fig. 2. 
4. The cytoehrome b component 
The single heme in mammalian and E. coli SQR and the 
two hemes in B. subtilis SQR have bis-histidine axial ligation 
as demonstrated by EPR spectroscopy combined with low- 
temperature near-infrared MCD spectroscopy [13-15]. The 
ligand histidine residues have been identified in the primary 
sequence of the B. subtilis and E. coli SQR anchor polypep- 
tides by site directed mutagenesis analysis [12,16,17]. These 
residues are located in predicted transmembrane segments as 
shown in Fig. 2 (top panel). In the mono-heme E. coli SQR 
one ligand is provided by SdhC and the other by SdhD, i.e. 
the heme is ligated by both polypeptides [17]. In the diheme 
anchors the heme axial ligands are distributed over 4 trans- 
membrane segments. 
5. Primary structure comparisons 
Fig. 3 is an alignment of the deduced primary sequences of 
anchor polypeptides from 16 different succinate:quinone oxi- 
doreductases. The alignment isbased on the conserved pattern 
of predicted transmembrane segments and the histidine resi- 
dues identified as axial ligands in B. subtilis and E. coli SQR. 
For the purpose of comparison we have included sequences 
from three type D anchors, namely those of S. cerevisiae SQR 
(ScS), E. coli QFR (EcF) and Haemophilus influenzae QFR 
Table 1 
Types of membrane anchors in succinate:quinone oxidoreductases 
(HiF). Several conclusive features are apparent from the align- 
ment: (i)Two histidines, one in helix II and one in helix V, 
known to ligate the high potential heine (bH) in B. subtilis 
SQR and the single heme in E. coli SQR, are present in all 
the heme-containing anchors, i.e. those of types A C. The two 
histidines in helices I and IV that ligate heme bL in B. subtilis 
SQR, are only present in the type A and B anchors (BsS, WsF 
and TaS). This confirms the assignment of axial ligands and 
makes it possible to predict the heme content from primary 
sequence in those anchors for which no biochemical data is 
available. (ii) Helix III is absent in the type B anchors (Figs. 2 
and 3). (iii) The hydrophilic segments on the negative side of 
the membrane, i.e. the N-terminal ends and the (inside) loops 
connecting transmembrane segments, are rich in residues with 
positively charged side chains that can act as stop-transfer 
signals when the polypeptide is inserted into the membrane. 
The eucaryotic anchor polypeptides, i.e. those of B. taurus and 
S. cerevisiae, are as deduced from the DNA sequence synthe- 
sised with a N-terminal, cleaved, extension of about 30 resi- 
dues that presumably functions as a mitochondrial inner- 
membrane targeting sequence (Fig. 3) [18-20]. The N-terminal 
end of the bacterial polypeptides function as signal peptides 
[12] but are essentially not processed, i.e. four residues are 
removed from E. coli SdhC [21] and the initiating-methionine 
in B. subtilis SdhC [22] is removed in about 50% of the cases. 
(iv) Proline and glycine residues are frequent in the hydrophi- 
lic segments, upporting the view that these parts are structur- 
ally flexible to function as connecting loops. (v) Conserved 
motifs (marked in Fig. 3) are present and mainly in segments 
exposed on or close to the negative side of the membrane. 
This probably reflects the fact that these parts interact with 
or directly bind to the Fp and Ip subunits. It is known that 
both polypeptides in type C and D anchors are required for 
the binding of Fp and Ip [1,17]. A mutation (the conserved 
6168 -* D) in the loop between helices V and VI in B. subtilis 
SdhC blocks binding of Fp and Ip [2,12]. Two carboxyl 
groups and one histidine residue in the bovine SdhD polypep- 
Type of No. of No. of Example ofenzymes of respective 
anchor polypeptides heroes type 
Quinone ~ Properties of cytochrome b References 
Em (mV) EPR signal(s) 
(g,n~,) 
A 2 2 
B 1 2 
C 2 1 
D 2 0 
Thermoplasma acidophilum SQR CQ 
Bacillus subtilis SQR MQ 
Wolinella succ#1ogenes QFR MQ 
ba ; +75 3.2 [46,47] 
bL; --150 
ba ; +65 b~ ; 3.68 [48] 
bL ; --95 bL; 3.42 
bH ; --20 n.d. [49] 
bL ; --200 
Bos taurus heart SQR UQ 185 3.46 [15,50] 
Escheriehia coli SQR UQ +36 3.63 [14,51] 
Paracoccus denitrificans SQR UQ - 175 c n.d. [52] 
Adult Ascaris suum QFR RQ -34 3.6 [7,53] 
Sulfolobulus acidocaldarius SQR CQ 
Escherichia coli QFR MQ 
Saccharomyces cerevisiae SQR a UQ 
[54,551 
[1,561 
[571 
~CQ, caldariella quinone; MQ, menaquinone; UQ, ubiquinone; RQ, rhodoquinone. 
bThe redox data are for the isolated enzyme or cytochrome atpH 7 7.5. bH and bL denote the high- and low-potential cytochrome 
respectively, n.d., no data available. 
CM. Matsson and L. Hederstedt, unpublished data. 
dIt still needs to be confirmed that yeast SQR lacks heme [19]. 
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Fig. 1. Composition and organisation of succinate:quinone oxidoreductases. 
-I- 
tide are important for binding the peripheral domain [23,24]. 
Conserved residues involved in quinone binding are also ex- 
pected. The loop between helices II and III has been pin- 
pointed in bovine SdhC using photoaffinity labelling of SQR 
with a quinone analogue [25]. Mutations in the outer loop 
close to helix V in E. coli FrdD (F57--*V, Q59--~V, and 
$60 ~A)  affect quinone oxidoreductase activity [26]. Type B 
anchors, composed of one polypeptide (i.e. BsS and WsF), 
show common motifs different from those of the two subunit 
anchors. These type B anchors both interact with menaqui- 
none (Table 1). (vi) SdhC and SdhD polypeptides show se- 
quence similarity. For example, the H/Q R/AxxG/A motif in 
the beginning of helices I and IV, and the HxxxGxxxxxx D 
motif at the end of helices II and V. This suggests that the 
sdhC and sdhD genes have originated by duplication of a 
primordial gene. The sdhC and sdhD genes as well as the 
frdC and frdD genes are adjacent in bacteria, and cotran- 
scribed in the direction C to D [1,2]. In eukaryotic organisms 
the genes for Fp, Ip and the anchor polypeptides are generally 
encoded by unlinked nuclear genes (cf. [19,20,27-29]). How- 
ever, very recently it has been found that the mitochondrial 
genomes of the photosynthetic red algae Porphyra purpurea, 
Chondrus crispus and Cyanidium caldarium, the zooflagelate 
Rectinomonas mericana nd the liverworth Marchantia poly- 
morpha carry genes for SQR anchor polypeptides and in some 
cases also the gene for Ip [30,31]. In P. purpurea and R. 
americana the sdhC and sdhD genes are arranged as in bacter- 
ia, whereas in Ch. crispus and M. polymorpha they are sepa- 
rated. The SdhC sequences deduced from these mitochondrial 
genes are similar to those of nuclear and bacterial genes. In 
contrast, the corresponding SdhD (PpS, CrS, MpS) deviate in 
sequence from other SdhD polypeptides, i.e. the loop between 
helices IV and V is missing and the sequence at the C-termi- 
nus is very polar. The deduced sequences of the mitochondria 
encoded sdhC and sdhD genes lack the above-mentioned N- 
terminal targeting sequence found in the nuclear encoded an- 
chor proteins. It remains to be determined whether the mito- 
chondrial sdhC and sdhD encode functional proteins or if they 
are pseudo-genes. (vii) Helices I l l  and VI are overall poorly 
conserved in sequence, indicating that they do not play central 
roles in the function of the anchors. E. coli QFR anchor 
polypeptide mutants lacking one or two complete helices at 
the C-terminal end show substantial quinone reductase activ- 
ity but are impaired in binding the peripheral domain [32]. 
6. A 3-dimensional structural model 
Predictions of 3-dimensional structure of proteins from pri- 
mary sequence data are rather ambiguous but much less so 
for the membrane-integral domain of ct-helical polytopic 
membrane-proteins. This is due to the 2-dimensional restric- 
tion in space impeded by the membrane bilayer. If the trans- 
membrane topology of the different ct-helical segments is 
known and the number of helices is small only a few structur- 
al variants are possible. This number of variants is further 
restricted when ligands to prosthetic groups have to be taken 
into account in the structure. Accordingly, the four heme-li- 
gating transmembrane helices of the diheme B. subtilis mem- 
brane anchor (type B) can principally be arranged in only 
three alternative ways. The preferred structural model is 
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Fig. 2. Proposed structure of the membrane-integral domain. The upper part of the figure shows the topology of B. subtilis SdhC in the mem- 
brane as verified experimentally [12] and that for the others as predicted (see text for details). The location of histidine residues identified as 
heme-iron axial ligands in the B. subtilis [12] and the E. eoli [17] proteins are indicated. Those of 7". acidophilum are deduced from sequence 
data (see Fig. 3). The ligands to heme bH and heme bL in the diheme proteins are indicated • and ©, respectively. 
that which gives a conserved structure for all succinate:qui- 
none oxidoreductases, which does not require complicated 
folding of hydrophilic loops and which is consistent with ac- 
cumulated experimental data. 
Shown in Fig. 2 (bottom middle) is the 3-dimensional struc- 
tural model that we find most likely to be correct for the B. 
subtilis membrane anchor (type B). It also applies to type A and 
C anchors (Fig. 2) and probably those of type D (not shown). 
Figures of rejected alternative structures are available from the 
authors upon request; they require that the loops between he- 
lices I and II and between IV and V intersect or are difficult to 
envisage from an evolutionary point of view (discussed below). 
The core of the proposed structure is a four helix anti-par- 
allel bundle comprised of helices I, II, IV and V. The heme 
group(s) is oriented approximately perpendicular to the mem- 
brane plane. The two hemes in the type A and B anchors are 
essentially positioned on the same transmembrane vector but 
in perpendicular orientation to each other. The large gm~×- 
type low-spin EPR signal from heme iron (Table 1) indicates 
a nearly perpendicular relative orientation of the planes of the 
two imidazole groups being axial ligands to each heme and a 
geometrically somewhat 'strained' bond between the tele-ni- 
trogen of histidine and the iron atom [13,33]. The heme mol- 
ecules in the bundle are most likely oriented such that the 
propionate side groups are at the membrane surface making 
electrostatic or hydrogen bonding to residues at the end of 
transmembrane segments or in loops, as is the case in cyto- 
chrome oxidase [3]. We wish to emphasise that the model is 
only schematically presented in Fig. 2, to illustrate clearly the 
organisation and topology of the transmembrane s gments 
and the ligation of hemes. In the authentic membrane-bound 
protein helices II and V can be somewhat tilted relative to 
both the membrane plane and each other; i.e. the ends of 
these helices can be closer together at the negative side of 
the membrane to ligate heme bH and more distant at the 
positive side of the membrane to accommodate he heme bL 
molecule. Helices I and V would be arranged correspondingly 
to ligate heme bE and leaving room for heme bH. Modelling 
work with the proposed structure has not provided geometric 
arguments against he structure. Degli Esposti et al. [34] have 
previously suggested a four-helix bundle structure for the 
membrane anchor of W. succinogenes QFR with the two 
hemes at its centre, but that structure is different from the 
one we propose here since it was based on another transmem- 
brane topology for the anchor polypeptide. 
The position of helix VI in the type B anchors, and helices III 
and VI in that of types A and C, cannot be predicted with any 
certainty. We have tentatively chosen to put these helices where 
they could interact with N-terminal ends and act as 'hydro- 
phobic zippers' to stabilise the four helix bundle (Fig. 2). 
Hexa-coordinated heine probably stabilises the structure by 
'cross-linking' the helices in the bundle. The two heme groups 
in type B anchors may be needed to compensate for the lack of 
helix III. Helix III might for a similar eason stabilise the type 
C and D anchors lacking one and both hemes, respectively. 
In Fig. 4 the proposed four helix anti-parallel bundle is 
presented in the form of a helical wheels plot with the type 
A anchor of T. acidophilum SQR as an example. A 2-fold axis 
of symmetry is apparent in the structure, most clearly seen in 
the constellation of conserved residues in the top segment 
around heme (bH). Statistical calculations using the sequence 
data for the heme-containing anchors, and that of S. cerevi- 
siae, show that hydrophobic residues are predominantly pres- 
ent on the outer surface of the bundle facing lipids (Fig. 4). 
Several conserved residues are oriented towards the centre of 
the bundle, close to heme (bH). The residues in the bottom 
segment in type C anchors are less conserved and have more 
bulky side chains as compared to those in types A and B 
(Figs. 3 and 4). This is consistent with the lack of heme bE 
in the type C anchors. It should be noted that the type C 
anchor sequences dominate in the results of the statistical 
analysis hown in Fig. 4. 
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Fig. 3. Sequence alignment of succinate:quinone oxidoreductase anchor polypeptides. Stars indicate the start and end of polypeptides. Amino 
acid residues are in the one-letter code. The alignment is based on histidines (marked in red) serving as axial ligands to heme iron and located 
in predicted transmembrane c~-helical segments (marked in green). Membrane-spanning segments are for simplicity defined as 20 residues in 
length, mainly with hydrophobic residues and preferentially with aromatic residues at the ends. Sequences in the loops connecting transmem- 
brane segments are aligned with the bias to show similarities and avoid gaps. Conserved motifs are marked in blue and those present in both 
anchor polypeptides are indicated in yellow. Inside is the matrix side in mitochondria nd the cytoplasm in bacteria nd is the side on which 
the peripheral domain is bound. The organisms, enzyme and accession umbers (Genebank or Swiss Prot) or reference are: BsS, Bacillus subtilis 
SQR (P08064); WsF, Wolinella succinogenes QFR (P17413); TaS, Thermoplasma acidophilum SQR (X70908), BoS, Bos taurus SQR (P35720); 
EcS, Escheriehia coli SQR (P10466, P10445); PdS, Paracoccus dentrificans SQR (U31902); CbS, Coxiella burnetii (SQR (L33409); RpS, Rickett- 
sia prowazekii SQR P41085, P41086); RaS, Rectinomonas mericana SQR [30]; Ccs, Cyanidum caldarium SQR (P48935); PpS, Porphyra purpurea 
SQR [30]; CrS, Chondrus crispus SQR (P48934); MpS, Marchantia polymorpha (P35721, M68929); ScS, Saecharomyces cerevisiae SQR (P33421, 
P37298), EcF, E. coli QFR (P03805, P03806); HiF, Haemophilus influenzae (QFR (P44892, P44891). DNA sequence information is also avail- 
able for Proteus vulgaris frdCD [58] and for hamster sdhC [27]. The deduced polypeptide sequences are very similar to E. eoli FrdCD and Bos 
taurus SdhC, respectively, and were therefore not included in the alignment. The N-terminus of the BsS [22], BoS [18], and ScS SdhC [20] and 
SdhD [19] polypeptides as shown in Fig. 3 is that determined by analysis of polypeptide isolated from the respective enzyme. 
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The model is supported by various experimental data but 
due to page limitations only some of these can be mentioned 
here. For  example, the H13~Y mutation in helix I in the B. 
subtilis anchor strongly affects the properties of heine bH but 
not those of heme bL [12]. The position of H13 in the struc- 
tural model corresponds to I:2 (the second residue in helix I 
as viewed from the negative side of the membrane) assuming 
that the proline residue in helix I is an a-helix breaker as 
suggested from the sequence alignment (Fig. 3). In the helical 
wheel plots we have otherwise not considered proline residues 
in predicted transmembrane s gments as helix-breakers. The 
anchor polypeptides of E. coli QFR have been subjected to 
extensive random and site specific mutagenesis [26,32,35,36]. 
Among residues identified as important for quinone reduction 
and/or quinol oxidation are E29 (I:2), A32 (I:5), Hs2 (II:6), 
Ws6 (II:2), Fs7 ( I I : l )  and Hs0 (V:3). These residues have been 
proposed to contribute to a 'QB site' [26] and are (with the 
exception of F87) clustered in the structural model. Residues 
of the postulated 'QA site' are the in section 5 mentioned 
residues in the outside loop between helices IV and V [26]. 
A few identified functionally important residues like Fas ( I : l  1) 
would be positioned on the outside of helix I in the middle of 
the membrane and interact with helix VI. 
7. Impl icat ions from the sequence comparisons and the model 
From the data presented in this paper one can speculate on 
how the membrane-anchor domains of succinate:quinone oxi- 
doreductases have evolved. The ancestral anchor might first 
have been comprised of a homo-dimer of a polypeptide simi- 
lar to today's SdhC polypeptides. This protein most likely 
carried the histidine residue corresponding to that in helix II 
of present anchors, and could also have contained the one in 
helix I of present ype A and B anchors, and the dimer pos-  
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Fig. 4. Helical wheels plot of transmembrane s gments I, II, IV and V in the structural model. The sequence of the T. acidophilum embrane 
anchor domain is shown as an example and is combined with statistical data. Each helix comprises 20 residues (those indicated in Fig. 3), is 
viewed down from the negative side of the membrane, and is presented as two segments; top segment (residues 1 10) and bottom segment (res- 
idues 11 20). Amino acids are in the one-letter code and coloured consistent with Fig. 3. The residues in each helix are numbered from the 
negative side to the positive side. The top segment contains the histidine ligands to heme bH and the bottom segment those of heme bL. The 
bars extending from the centre of each wheel shows the result of a statistical analysis incorporating sequences of all type A-C anchors of Fig. 
3 and also that of S. cerevisiae, i.e. 14 sequences for helices I and II, and 12 for helices IV and V. Red bars show the frequency of occurrence 
in percent of the most common amino acid at the respective position (Fig. 3); i.e. the bar for H6 represents 100%. Blue bars show this fre- 
quency when conserved substitutions are taken into account• The calculated hydrophobic moment in each helix is shown in green shading. 
Conserved substitutions and the general hydrophobicity were calculated as in [59]. 
sibly contained heme. The gene for this polypeptide was then 
duplicated and this allowed for divergent evolution of the two 
polypeptides. This resulted in anchors of the present ypes A 
and C. The type B anchor was then derived from a type A 
anchor by the deletion of helix III and concomitant fusion of 
the obtained C-terminal to the N-terminal end of helix IV. 
Such a deletion could easily be accomplished as seen in Fig. 2. 
Type D anchors can have evolved directly from the ancestral 
type of polypeptide or from a type C anchor. 
The role of heme (cytochrome b) in sucinate:quinone oxi- 
doreductases i not understood [37]. Heme is clearly not ob- 
ligatory for succinate:quinone oxidoreductase activity, as de- 
monstrated by the enzymes with type D anchors and also by 
e.g.E, coli SQR mutants [17], and may thus have other func- 
tion(s). Electron transfer at significant rates between the pe- 
ripheral domain and cytochrome b has been demonstrated in
some cases c.f. [38] but it is not known whether electrons pass 
via heme upon quinone reduction or oxidation. In vivo ex- 
periments with B. subtilis and E. coli SQR suggest an impor- 
tant role of  heme in assembly of the enzyme [17,39]. It is, as 
mentioned in connection with helix In,  plausible that heine 
functions to stabilise the four helix bundle of the proposed 
structure. Such a function of heme and metal has been dem- 
onstrated with designed water-soluble four helix bundle struc- 
tures [40,41]. The alignment of the type D anchor polypep- 
tides with those of types A -C  is uncertain due to the overall 
weak sequence similarities (Fig. 3). Notable is that the S. 
cerevisiae (ScS) SdhC polypeptide shows clear sequence simi- 
larity to type C anchors, whereas SdhD does not. It cannot be 
excluded that the sequenced S. cerevisiae sdhC [20,42] and 
sdhD [19] genes encode anchor peptides of two different suc- 
cinate:quinone oxidoreductases; a sdhD knockout mutant still 
contained SQR activity [19]. Generally, however, it seems as if 
the conserved histidine of helix II (ligand to heme bH) is pres- 
ent also in type D anchors despite the lack of heine. The 
histidine in helix V (second ligand to heme bH) appears to 
correspond to a cysteine residue in the type D anchors. This 
raises the question of whether the type D anchors contain 
some small prosthetic group, e.g. a metal atom such as iron, 
with the histidine and cysteine residues as ligands. Such a 
group could, as for heme, stabilise the four helix bundle or 
play a role in electron transfer to/from quinone. The con- 
served histidine (Hs2) in helix II of E. coli FrdC has been 
mutagenised and this affects quinone reductase to various ex- 
tent depending on the substitution [26,35]. 
Our proposed model indicates that the cytochromes b in 
diheme succinate:quinone oxidoreductases play some role in 
transmembrane lectron-transfer. The two cytochromes b 
(both with bis-histidine axial ligation) in quinol:cytochrome 
c reductase (complex III) have such a function. The arrange- 
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ment of the heme groups in the membrane-integral domain of 
these two enzymes is, however, very different [43]. In quinol:- 
cytochrome c reductase the two heroes are ligated by only two 
transmembrane helices; each pair of histidines on the two 
helices are 13 14 residues apart. As a consequence, the two 
hemes are approximately oriented in the same plane and posi- 
tioned at a fixed distance, 20 A, [5], from each other. In the 
diheme succinate:quinone oxidoreductases the relative posi- 
tion of the two hemes can be more flexible. The heme-heme 
distance might, at least theoretically, be modulated in the 
enzyme and could be a way to, e.g. regulate electron-transfer 
rates between the hemes. There are several examples of di- 
heme integral membrane-bound cytochromes b with axial 
heme ligands distributed over more than two transmembrane 
segments; e.g. cytochrome b-561 of chromaffin granule [44] 
and cytochrome b of phagocyte NADPH oxidase [45], We 
hope the proposed general structural model of the mem- 
brane-integral domain of succinate:quinone oxidoreductases 
can help in the design of  experiments aimed at a better under- 
standing of the structure and function also of these other 
cytochromes. 
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